1-6 of 6
Guy Jerusalem
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer

Matthew P. Goetz, Erika P. Hamilton, Mario Campone, Sara A. Hurvitz, Javier Cortes, Stephen Johnston, Antonio Llombart-Cussac, Peter A. Kaufman, Masakazu Toi, Guy Jerusalem, Hillary Graham, Hong Wang, Valerie M. Jansen, Lacey M. Litchfield, Miguel Martin
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2233–2244.
https://doi.org/10.1158/1078-0432.CCR-22-3573
Published: 15 May 2024
View article titled, Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer
Open the PDF for Landscape of Baseline and Acquired Genomic Alterations in Circulating Tumor DNA with Abemaciclib Alone or with Endocrine Therapy in Advanced Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial

Elena Guerini-Rocco, Kathryn P. Gray, Caterina Fumagalli, Marta Rita Reforgiato, Isabella Leone, Paola Rafaniello Raviele, Elisabetta Munzone, Roswitha Kammler, Patrick Neven, Erika Hitre, Guy Jerusalem, Edda Simoncini, Andrea Gombos, Ines Deleu, Per Karlsson, Stefan Aebi, Jacquie Chirgwin, Vincenzo Di Lauro, Alastair Thompson, Marie-Pascale Graas, Matthew Barber, Christel Fontaine, Sibylle Loibl, Joaquín Gavilá, Katsumasa Kuroi, Bettina Müller, Seamus O’Reilly, Angelo Di Leo, Aron Goldhirsch, Giuseppe Viale, Massimo Barberis, Meredith M. Regan, Marco Colleoni
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (2): 504–512.
https://doi.org/10.1158/1078-0432.CCR-20-0126
Published: 19 January 2021
View article titled, Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial
Open the PDF for Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial in another window
Includes: Supplementary data
Journal Articles

Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy

Pierre Foidart, Cassandre Yip, Jean Radermacher, Silvia Blacher, Mehdi Lienard, Laetitia Montero-Ruiz, Erik Maquoi, Elodie Montaudon, Sophie Château-Joubert, Joëlle Collignon, Michel Coibion, Véronique Jossa, Elisabetta Marangoni, Agnès Noël, Nor Eddine Sounni, Guy Jerusalem
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (6): 1838–1850.
https://doi.org/10.1158/1078-0432.CCR-18-1880
Published: 15 March 2019
View article titled, Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy
Open the PDF for Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy in another window
Includes: Supplementary data
Journal Articles

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

Cristina Saura, Johanna Bendell, Guy Jerusalem, Shaun Su, Qinhua Ru, Stefan De Buck, David Mills, Sophie Ruquet, Ana Bosch, Ander Urruticoechea, Joseph T. Beck, Emmanuelle Di Tomaso, David W. Sternberg, Cristian Massacesi, Samit Hirawat, Luc Dirix, Jose Baselga
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (7): 1935–1945.
https://doi.org/10.1158/1078-0432.CCR-13-1070
Published: 31 March 2014
View article titled, Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy
Open the PDF for Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy in another window
Includes: Supplementary data
Journal Articles

Sequential Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Response to Chemotherapy in Metastatic Breast Cancer

Olivier Couturier, Guy Jerusalem, Jean-Michel N'Guyen, Roland Hustinx
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (21): 6437–6443.
https://doi.org/10.1158/1078-0432.CCR-06-0383
Published: 03 November 2006
View article titled, Sequential Positron Emission Tomography Using [<sup>18</sup>F]Fluorodeoxyglucose for Monitoring Response to Chemotherapy in Metastatic Breast Cancer
Open the PDF for Sequential Positron Emission Tomography Using [<sup>18</sup>F]Fluorodeoxyglucose for Monitoring Response to Chemotherapy in Metastatic Breast Cancer in another window
Journal Articles

Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis

Tarik Belhocine, Neil Steinmetz, Roland Hustinx, Pierre Bartsch, Guy Jerusalem, Laurence Seidel, Pierre Rigo, Allan Green
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (9): 2766–2774.
Published: 01 September 2002
View article titled, Increased Uptake of the Apoptosis-imaging Agent <sup>99m</sup>Tc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis
Open the PDF for Increased Uptake of the Apoptosis-imaging Agent <sup>99m</sup>Tc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis in another window